Institute of Cancer Research. Division of Cancer Therapeutics Hubs
The division aims to exploit the vulnerabilities of cancer cells by discovering novel and innovative small-molecule drugs for the personalised treatment of cancer. The division also develops biomarkers designed to confirm the effectiveness of molecularly targeted therapies, and help doctors to determine which therapy will benefit each patien
Technology:
Hubs
Industry:
R&D
Headquarters:
South Kensington, Royal Borough of Kensington and Chelsea, London, Greater London, England, SW7 4PH, United Kingdom
Register and Claim Ownership